BetterLife Pharma (BETRF) Accounts Payables (2011 - 2026)
BetterLife Pharma (BETRF) posted quarterly Accounts Payables of $2.9 million for Q2 2026, up 4.17% year-over-year from $2.7 million in Q2 2025, and up 0.59% quarter-over-quarter from $2.8 million in Q1 2026.
BetterLife Pharma (BETRF) Accounts Payables (2011 - 2026) Analysis & Trends
BetterLife Pharma's Accounts Payables history runs 16 years deep, the most recent figure standing at $2.9 million for Q2 2026.
- In Q2 2026, Accounts Payables rose 4.17% year-over-year to $2.9 million; the TTM figure through Apr 2026 stood at $2.9 million (up 4.17% YoY), while the FY2026 annual figure was $2.8 million, down 10.09% from the prior year.
- Accounts Payables for Q2 2026 stood at $2.9 million, up from $2.8 million in the prior quarter.
- The five-year high for Accounts Payables was $3.9 million in Q4 2023, with the low at -$8.0 million in Q1 2023.
- The 5-year median for Accounts Payables is $3.4 million (2024), against an average of $2.3 million.
- The sharpest annual moves came in 2022 and 2024: Accounts Payables slumped 17717.2% in 2022, then jumped 146.29% in 2024.
- BetterLife Pharma's Accounts Payables stood at $3.7 million in 2022, then rose by 7.3% to $3.9 million in 2023, then slipped by 19.86% to $3.1 million in 2024, then slipped by 10.92% to $2.8 million in 2025, then rose by 2.08% to $2.9 million in 2026.
- Business Quant data shows BETRF's Accounts Payables at $2.9 million in Q2 2026, $2.8 million in Q1 2026, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | 2.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.86 Mn |
| Jan 31, 2026 | 2.85 Mn |
| Jul 31, 2025 | 2.81 Mn |
| Apr 30, 2025 | 2.75 Mn |
| Jan 31, 2025 | 3.17 Mn |
| Oct 31, 2024 | 3.15 Mn |
| Jul 31, 2024 | 3.48 Mn |
| Apr 30, 2024 | 3.39 Mn |
| Jan 31, 2024 | 3.68 Mn |
| Oct 31, 2023 | 3.93 Mn |
| Jul 31, 2023 | 3.81 Mn |
| Apr 30, 2023 | 3.78 Mn |
| Jan 31, 2023 | -7.95 Mn |
| Oct 31, 2022 | 3.66 Mn |
| Jul 31, 2022 | 3.82 Mn |
| Apr 30, 2022 | 3.79 Mn |
| Jan 31, 2022 | -3.07 Mn |
| Oct 31, 2021 | 2.60 Mn |
| Jul 31, 2021 | 2.91 Mn |
| Apr 30, 2021 | 3.08 Mn |